News Daily News Side Effects of Statins Might Be Overstated: CTT Collaboration Michael O'Riordan February 12, 2026
News Daily News Statins Work for Primary Prevention Even in Low-risk Patients With Type 2 Diabetes Todd Neale January 05, 2026
News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Conference News AHA 2025 Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia Caitlin E. Cox November 08, 2025
News Conference News AHA 2025 CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia Todd Neale November 08, 2025
News Daily News Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis Yael L. Maxwell October 24, 2025
News Features Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile Michael O'Riordan October 17, 2025
News Daily News New ACC Consensus Document Helps Clinicians Navigate Issues Around TR Todd Neale September 26, 2025
News Conference News ESC 2025 Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF Michael O'Riordan August 29, 2025
News Daily News Gut Microbes Linked to Risk of Abdominal Aortic Aneurysms Michael O'Riordan August 20, 2025
News Daily News Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol Michael O'Riordan August 06, 2025
News Daily News AF Patients Could Benefit From Exercise-Based Cardiac Rehab Caitlin E. Cox August 05, 2025
News Daily News AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty Caitlin E. Cox June 13, 2025
News Conference News European Congress on Obesity 2025 Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity Michael O'Riordan May 16, 2025
News Conference News European Congress on Obesity 2025 Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery Michael O'Riordan May 14, 2025
News Conference News EAS 2025 Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM Yael L. Maxwell May 08, 2025
News Daily News Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention Michael O'Riordan May 07, 2025
News Conference News CX Symposium 2025 Plant-Derived Compound Shows Early Promise for Small AAAs L.A. McKeown April 25, 2025
News Daily News Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy Caitlin E. Cox April 14, 2025